BACKGROUND: Generalized anxiety disorder (GAD) is a common and serious disease with a lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care. METHODS: Recommendations on the treatment of GAD are given on the basis of all available findings from pertinent randomized trials, retrieved by a selective search of the literature. RESULTS: Among psychotherapeutic techniques, various kinds of cognitive behavioral therapy (CBT) have been found useful in controlled trials. The drugs of first choice include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephine reuptake inhibitors (SNRIs), and the calcium-channel modulator pregabalin. Tricyclic antidepressants are also effective but have more adverse effects than SSRIs. Although benzodiazepines are effective anxiolytic agents for short-term use, they should not be given over the long term because of the danger of addiction. Buspirone, an azapirone, was found to be effective in a small number of trials, but the findings across trials are inconsistent. The response rate of GAD to CBT in published studies lies between 47% and 75%, while its response rate to drug treatment lies between 44% and 81%. CONCLUSION: The treatment of GAD with CBT and drugs is evidence-based and has a good chance of improving the manifestations of the disorder.
BACKGROUND:Generalized anxiety disorder (GAD) is a common and serious disease with a lifetime prevalence of 4.3% to 5.9%. It is underdiagnosed in primary care. METHODS: Recommendations on the treatment of GAD are given on the basis of all available findings from pertinent randomized trials, retrieved by a selective search of the literature. RESULTS: Among psychotherapeutic techniques, various kinds of cognitive behavioral therapy (CBT) have been found useful in controlled trials. The drugs of first choice include selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephine reuptake inhibitors (SNRIs), and the calcium-channel modulator pregabalin. Tricyclic antidepressants are also effective but have more adverse effects than SSRIs. Although benzodiazepines are effective anxiolytic agents for short-term use, they should not be given over the long term because of the danger of addiction. Buspirone, an azapirone, was found to be effective in a small number of trials, but the findings across trials are inconsistent. The response rate of GAD to CBT in published studies lies between 47% and 75%, while its response rate to drug treatment lies between 44% and 81%. CONCLUSION: The treatment of GAD with CBT and drugs is evidence-based and has a good chance of improving the manifestations of the disorder.
Authors: Karl Rickels; Thomas M Shiovitz; Tanya S Ramey; Jerry J Weaver; Lloyd E Knapp; Jeffrey J Miceli Journal: Int Clin Psychopharmacol Date: 2012-05 Impact factor: 1.659
Authors: Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters Journal: Arch Gen Psychiatry Date: 2005-06
Authors: Martin A Katzman; Olga Brawman-Mintzer; Efren B Reyes; Bengt Olausson; Sherry Liu; Hans Eriksson Journal: Int Clin Psychopharmacol Date: 2011-01 Impact factor: 1.659
Authors: Atul C Pande; Jerri G Crockatt; Douglas E Feltner; Carol A Janney; Ward T Smith; Richard Weisler; Peter D Londborg; Robert J Bielski; Dan L Zimbroff; Jonathan R T Davidson; Maria Liu-Dumaw Journal: Am J Psychiatry Date: 2003-03 Impact factor: 18.112
Authors: Steven D Targum; Christopher Murphy; Jibran Khan; Laura Zumpano; Mark Whitlock; Arthur A Simen; Brendon Binneman Journal: Innov Clin Neurosci Date: 2018-04-01
Authors: Anita R Peoples; Peter W Bushunow; Sheila N Garland; Charles E Heckler; Joseph A Roscoe; Luke L Peppone; Deborah J Dudgeon; Jeffrey J Kirshner; Tarit K Banerjee; Judith O Hopkins; Shaker R Dakhil; Marie A Flannery; Gary R Morrow Journal: Support Care Cancer Date: 2015-09-02 Impact factor: 3.603